![]() |
市場調查報告書
商品編碼
1957218
單極電外科器材市場-全球產業規模、佔有率、趨勢、機會、預測:按類型、應用、最終用途、地區和競爭對手分類,2021-2031年Monopolar Electrosurgery Instrument Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By End Use, By Region & Competition, 2021-2031F |
||||||
全球單極電外科器械市場預計將從 2025 年的 38.9 億美元成長到 2031 年的 50.1 億美元,複合年成長率為 4.31%。
該市場以使用單一活性電極向特定組織輸送電流的設備為特徵,需要患者側的回流電極來完成迴路,以實現有效的切開和凝血。推動市場成長的主要因素包括:需要手術介入的慢性疾病數量不斷增加、全球人口老化以及全球手術數量的持續成長。這些因素使得急診護理領域對可靠設備的需求日益迫切,而強勁的經濟環境也支撐著這項需求。根據歐洲醫療技術協會(MedTech Europe)預測,到2024年,歐洲醫療技術市場規模將達到約1,700億歐元。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 38.9億美元 |
| 市場規模:2031年 | 50.1億美元 |
| 複合年成長率:2026-2031年 | 4.31% |
| 成長最快的細分市場 | 醫院 |
| 最大的市場 | 北美洲 |
儘管市場成長勢頭強勁,但由於醫療設備核准監管條件嚴格,市場仍面臨許多障礙。製造商必須應對複雜的合規要求,例如歐盟醫療設備法規 (MDR) 的規定,這會顯著增加研發成本並延緩產品上市。這些監管負擔對中小企業構成准入壁壘,並可能透過減緩新技術應用而阻礙市場整體擴張步伐。
隨著微創手術需求的不斷成長,單極電外科器械的全球市場需求也日益旺盛。這些高度依賴電外科精準操作以減輕患者身體負擔的技術正被廣泛應用。單極器械,包括主動電極和腹腔鏡鉤,對於此類手術至關重要,因為它們能夠在有限的解剖空間內提供必要的切割和凝血功能。採用專用電外科末端執行器的機器人平台的日益普及進一步強化了這一趨勢。特別是,直覺外科公司(Intuitive Surgical)在2025年1月發布的報告顯示,2024年全球達文西手術數量將增加約17%,證實了手術數量的成長正在推動器械的使用。
同時,慢性疾病(尤其是癌症)發生率的不斷上升,正成為市場成長的主要驅動力,因為這些疾病需要頻繁的手術介入。電外科手術仍然是腫瘤切除和組織處理的標準治療方法,確保了在急診環境中對可靠的單極電外科設備持續的需求。美國癌症協會 (ACS) 截至 2024 年 1 月的預測顯示,2024 年美國新增癌症病例將超過 200 萬例,這將導致對外科治療的需求顯著增加。製造商正在部署大規模商業生產以滿足這一需求。Medtronic於 2024 年 5 月發布的一份報告顯示,其醫療外科產品組合創造了 84 億美元的收入,這反映了這一關鍵外科基礎設施的巨大規模。
醫療設備認證的嚴格法規環境對全球單極電外科器械市場的成長構成重大阻礙。歐盟醫療設備管理局 (FDA) 標準等框架,要求提供比以往任何時候都更全面的臨床證據和更嚴格的上市後監管。這種日益嚴格的監管迫使製造商將更多的資金和時間投入到合規性方面,而非研發。對於需要頻繁更新電極形狀和發生器相容性的電外科器械而言,冗長的核准流程會延緩產品開發,並限制創新技術的市場准入。
這項監管瓶頸正對企業的策略性上市決策產生重大影響。 MedTech Europe 2024年的數據顯示,選擇歐盟作為其新醫療設備首發主要市場的主要製造商數量較MDR實施前下降了33%。這項數據清楚地表明,監管的複雜性正迫使企業放棄一些關鍵市場。因此,先進單極電外科器械的普及速度正在放緩,直接降低了收入潛力,並阻礙了全球市場的整體成長。
旨在提升手術室職業安全的嚴格法律法規正推動將排煙裝置整合到牙科手機中,這已成為一項重要的市場趨勢。監管機構和州立法機構日益認知到手術煙霧的健康風險,並強制要求醫療機構將標準筆式手柄更換為內置吸力功能的活性電極手柄。這種監管壓力迫使醫院採用符合規定的設備,以避免處罰並保護員工。根據《ASC Focus》雜誌2024年5月刊報道,明尼蘇達州、維吉尼亞和西維吉尼亞於2024年頒布了手術煙霧排放法,使美國擁有此類法律的州總數達到18個,進一步推動了對具有排放功能的設備的需求。
同時,門診和日間手術中心採購量的增加正在從根本上改變買方結構,將需求從傳統的急診醫院轉移出去。這些機構優先考慮營運效率和高患者處理能力,因此需要經濟高效且可靠的單極器械,用於常規手術。手術量轉移到低成本環境的轉移正在為製造商建立強大的銷售管道。這項變更在領先的門診機構營運商的財務表現中顯而易見;例如,根據 Becker's ASC Review 2024 年 10 月的報告,United Surgical Partners International 第三季度收入成長了 21%,這反映了門診手術量激增,從而推動了器械消耗。
The Global Monopolar Electrosurgery Instrument Market is projected to expand from a valuation of USD 3.89 Billion in 2025 to USD 5.01 Billion by 2031, reflecting a compound annual growth rate of 4.31%. This market is characterized by the use of devices that utilize a single active electrode to deliver electrical current to specific tissues, necessitating a patient return electrode to complete the circuit for effective cutting and coagulation. Growth is primarily driven by the increasing prevalence of chronic diseases that require surgical intervention, a globally aging population, and a steady rise in the volume of surgical procedures worldwide. These factors create a crucial need for reliable instrumentation in acute care, a demand supported by a robust economic environment where the European medical technology market was valued at roughly €170 billion in 2024, according to MedTech Europe.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 3.89 Billion |
| Market Size 2031 | USD 5.01 Billion |
| CAGR 2026-2031 | 4.31% |
| Fastest Growing Segment | Hospitals |
| Largest Market | North America |
Despite this positive growth trajectory, the market encounters significant hurdles due to the rigorous regulatory landscape governing medical device approvals. Manufacturers are required to navigate complex compliance mandates, such as the European Union Medical Device Regulation (MDR), which can substantially inflate development costs and postpone product launches. These regulatory burdens frequently establish barriers to entry for smaller companies and decelerate the introduction of new technologies, potentially hindering the overall pace of market expansion.
Market Driver
The escalating demand for minimally invasive surgical procedures serves as a significant propellant for the Global Monopolar Electrosurgery Instrument Market, as these techniques depend heavily on electrosurgical precision to reduce patient trauma. Monopolar instruments, including active electrodes and laparoscopic hooks, are vital for these operations, offering necessary cutting and coagulation functions within confined anatomical spaces. This trend is reinforced by the growing adoption of robotic platforms utilizing specialized electrosurgical end-effectors; notably, Intuitive Surgical reported in January 2025 that worldwide da Vinci procedures increased by approximately 17% in 2024, underscoring the rising surgical volume driving instrument usage.
Concurrently, the increasing prevalence of chronic diseases, especially cancer, acts as a primary driver for market growth by requiring frequent surgical interventions. Electrosurgery continues to be a standard of care for tumor resection and tissue management, guaranteeing sustained demand for reliable monopolar devices in acute care environments. According to the American Cancer Society's January 2024 figures, over 2 million new cancer cases were projected to be diagnosed in the United States in 2024, creating a substantial requirement for surgical treatment. Manufacturers are meeting this need with significant commercial output, as evidenced by Medtronic's May 2024 report showing its Medical Surgical Portfolio generated $8.4 billion in revenue, reflecting the massive scale of this critical surgical infrastructure.
Market Challenge
The stringent regulatory environment surrounding medical device approval presents a major obstacle to the growth of the Global Monopolar Electrosurgery Instrument Market. Frameworks such as the European Union Medical Device Regulation (MDR) and evolving FDA standards now require more comprehensive clinical evidence and rigorous post-market surveillance than in the past. This heightened scrutiny compels manufacturers to divert substantial capital and time toward compliance efforts rather than research and development. For electrosurgical instruments, which frequently necessitate updates to electrode geometry and generator compatibility, these prolonged approval timelines delay product commercialization and limit the entry of innovative technologies.
This regulatory bottleneck significantly impacts strategic launch decisions, as demonstrated by MedTech Europe data from 2024 indicating a 33% decline in large manufacturers selecting the European Union as their primary geography for first launching new medical devices compared to the pre-MDR era. This statistic reveals a distinct shift where companies are deprioritizing major markets due to regulatory complexities. Consequently, the availability of advanced monopolar electrosurgery tools is retarded, which directly diminishes revenue potential and suppresses the overall expansion rate of the global market.
Market Trends
The integration of smoke evacuation mechanisms into handpieces is gaining momentum as a critical market trend, largely driven by strict legislative mandates designed to enhance occupational safety in operating rooms. Regulatory bodies and state legislatures are increasingly acknowledging the health risks associated with surgical smoke plumes, forcing facilities to switch from standard pencils to active electrodes equipped with built-in suction capabilities. This regulatory pressure compels hospitals to acquire compliant instrumentation to avoid penalties and protect staff; according to ASC Focus Magazine in May 2024, Minnesota, Virginia, and West Virginia enacted surgical smoke evacuation laws in 2024, raising the total number of U.S. states with such mandates to 18 and fueling demand for evacuation-enabled devices.
Simultaneously, the increased procurement by ambulatory and outpatient surgical centers is fundamentally altering the buyer landscape by shifting volume away from traditional acute care hospitals. These facilities emphasize operational efficiency and high patient throughput, requiring cost-effective and reliable monopolar instruments tailored for routine procedures. The migration of surgical volume to these lower-cost settings is establishing a robust sales channel for manufacturers, a shift highlighted by the financial results of leading outpatient operators; for instance, a report by Becker's ASC Review in October 2024 noted that United Surgical Partners International saw a 21% increase in third-quarter revenue, underscoring the surging procedural activity in outpatient settings that drives instrument consumption.
Report Scope
In this report, the Global Monopolar Electrosurgery Instrument Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Monopolar Electrosurgery Instrument Market.
Global Monopolar Electrosurgery Instrument Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: